Remove Clinical Practice Remove Complication Remove Illness Remove Information
article thumbnail

Deprescribing Super Special III: Constance Fung, Emily McDonald, Amy Linsky, and Michelle Odden

GeriPal

Join us as we dive deeper into these studies and discuss the implications for clinical practice and patient care. Emily 06:11 Yeah, we definitely have a pill for every ill. Alex 14:45 And is it ethical to do a placebo taper in real world clinical practice? Ethical and practical. Go ahead, Connie.

article thumbnail

Dysphagia Revisited: A Podcast with Raele Donetha Robison and Nicole Rogus-Pulia

GeriPal

Eric: And swallowing is complicated, right? So, we use that information to formulate a treatment plan. But again, most of my clinical practice, until recent years, has been in the acute care setting. Are there things that we can do to prevent the complication of aspiration, which we most fear, aspiration pneumonia?

IT 125
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Anxiety in Late Life and Serious Illness: A Podcast with Alex Gamble and Brianna Williamson

GeriPal

It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. I have so many questions, and I promise we’re going to get to the management of anxiety and serious illness. The question I would ask is, how helpful is that in our clinical practice?

Illness 130
article thumbnail

Cachexia and Anorexia in Serious Illness: A Podcast with Eduardo Bruera

GeriPal

Summary Transcript Summary I always find cachexia in serious illness puzzling. In today’s podcast, we had the opportunity to learn from a renowned expert in palliative care, Eduardo Bruera, about cachexia and anorexia in serious illness. I think the very simple, practical thing is involuntary weight loss. Alex 36:08 Yeah.

Illness 134
article thumbnail

What You Should Know About Radiation Oncology: Anish Butala, Emily Martin and Evie Kalmar

GeriPal

So in my practice, I typically recommend multi fraction or higher dose regimens for patients who have extra osseous extension or complicated bone Metastases, which, you know, most of the data surrounding equivalency of pain relief is in this sort of uncomplicated bone metastasis population. To their kind of systemic treatments.

article thumbnail

Psychedelics – reasons for caution: Stacy Fischer, Brian Anderson, Theora Cimino

GeriPal

FDA is considering approval, shifting away from Schedule I restrictions, paving the way for use in clinical practice. Two of our guests today, Stacy Fischer and Brian Anderson, are involved in large multicenter trials of psychedelics for patients with advanced cancer (Fischer) or life-limiting illness (Anderson). Eric: Yeah.

article thumbnail

POLST Evidence and Update: Kelly Vranas, Abby Dotson, Karl Steinberg, and Scott Halpern

GeriPal

And we have Scott Halpern, who is Professor of Medical Ethics and Health Policy and Director of the Palliative and Advanced Illness Research Center or Payer Center at the University of Pennsylvania. So I do think it’s useful to have that additional information. Alex: National POLST Collaborative. Good to know.